Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-01-11
2011-01-11
Cook, Lisa V (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007210, C436S501000, C436S506000, C436S518000, C422S050000, C422S067000, C530S300000, C530S350000, C424S009100
Reexamination Certificate
active
07867719
ABSTRACT:
The present invention provides β2 microglobulin as a biomarker for qualifying or assessing peripheral artery disease in a subject.
REFERENCES:
patent: 1 615 036 (2006-01-01), None
patent: 01/06262 (2001-01-01), None
Zumrutdal et al. (Nephrology, 2005, vol. 10, pp. 453-458).
Hamper et al.(Journal of the American Society of Nephrology, 2001, vol. 12, pp. 1026-1035).
Tatiana et al.(Renal Failure, 1994, vol. 16, No. 3, pp. 383-390, Abstract Only).
Galina et al. (Thrombosis and Vascular Biology, 2004, vol. 24, pp. 1359-1366).
Karlsson et al. (Proteomics, 2005, vol. 5, pp. 551-565).
O'Hare, A.M., et al.; “Cystatin C and incident peripheral arterial disease events in the elderly,” 2005,Arch. Intern. Med., vol. 165, pp. 2666-2670.
Nedelkov, D., et al.; “Design and use of multi-affinity surfaces in biomolecular interaction analysis-mass spectrometry (BIA/MS): a step toward the design of SPR/MS arrays,” 2003,Journal of Molecular Recognition, vol. 16, pp. 15-19.
Saijo, Y., et al.; “Relationships of β2-microglobulin to arterial stiffness in Japanese subjects,” 2005,Hybertens. Res., vol. 28, No. 6, pp. 505-511.
Schillinger, M., et al.; “Joint Effects of C-Reactive Protein and Glycated Hemoglobin in Predicting Future Cardiovascular Events of Patients With Advanced Atherosclerosis,” 2003,Circulation AHA Journals, pp. 2323-2328 (November).
Standl, E., et al., “Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practioner Project,” 1996,Diabetologia, vol. 39, pp. 1540-1545.
Thongboonkerd, V., et al.; “Proteomic analysis reveals alterations in the renal Kallikrein pathway during hypoxia-induced hypertension,” 2002,J. Biol. Chem., vol. 277, No. 33, pp. 34708-34716.
Cooke John
Fung Eric T.
Kimura Eiichiro
Ajinomoto Co. Inc.
Cook Lisa V
Corless Peter F.
Edwards Angell Palmer & & Dodge LLP
Hunter-Ensor, Esq. Melissa
LandOfFree
Beta-2 microglobulin as a biomarker for peripheral artery... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Beta-2 microglobulin as a biomarker for peripheral artery..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Beta-2 microglobulin as a biomarker for peripheral artery... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2739307